Surface plasmon resonance application in prostate cancer biomarker research

Chemical Papers

Volumn 69, Issue 1, 2015, Pages 143-149

  Damborský, Pavel ^a   Madaboosi, Narayanan ^b   Chu, Virginia ^b   Conde, João P ^b   Katrlík, Jaroslav ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b INSTITUTO SUPERIOR TÉCNICO   (Portugal)

Author keywords

antibody; biomarker; biospecific interaction; prostate cancer; prostate specific antigen; surface plasmon resonance

Indexed keywords

EID: 84916886438     PISSN: 03666352     EISSN: 13369075     Source Type: Journal    
DOI: 10.1515/chempap-2015-0053     Document Type: Article

References (21)

1. Black, M. H., Grass, C. L., Leinonen, J., Stenman, U. H., & Diamandis, E. P. (1999). Characterization of monoclonal antibodies for prostate-specific antigen and development of highly sensitive free prostate-specific an tigen assays. Clinical Chemistry, 45, 347-354.
2. Cao, C., Kim, J. P., Kim, B. W., Chae, H., Yoon, H. C., Yang, S. S., & Sim, S. J. (2006). A strategy for sensitivity and specificity enhanc ements in prostate specific antigen-?1-antichymotrypsin detection based on surface plasmon resonance. Biosensors and Bioelectronics, 21, 2106-2113. DOI: 10.1016/j.bios.2005.10.014.
3. Fukushima, K., Satoh, T., Bab a, S., & Yamashita, K. (2010). ?1,2-Fucosylated and ?-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer. Glycobiology, 20, 452-460. DOI: 10.1093/glycob/cwp197.
4. Gilg unn, S., Conroy, P. J., Saldova, R., Rudd, P. M., & O'Kennedy, R. J. (2013). Aberrant PSA glycosylation-A sweet predictor of prostate cancer. Nature Reviews Urology, 10, 99-107. DOI: 10.1038/nrurol.2012.258.
5. Goo, Y. A., & Goodlett, D. R. (2010). Advances in proteomic prostate cancer biomarker discovery. Journal of Proteomics, 73, 1839-1850. DOI: 10.1016/j.jprot.2010.04.002.
6. Haseley, S. R., Tala ga, P., Kamerling, J. P., Johannes, F. G., & Vliegenthart, J. F. G. (1999). Characterization of the carbohydrate binding specificity and kinetic parameters of lectins by using surface plasmon resonance. Analytical Biochemistr y, 274, 203-210. DOI: 10.1006/abio.1999.4277.
7. Hu, W. H., Li, C. M., Cui, X. Q., Dong, H., & Zhou, Q. (2007). In situ studies of protein adsorptions on poly(pyrrole-copyrrole propylic acid) film b y electrochemical surface plasmon resonance. Langmuir, 23, 2761-2767. DOI: 10.1021/la063024d.
8. Isono, T., Tanaka, T., Kageyama, S., & Yoshiki, T. (2002). Structural diversity of cancer-related and no n-cancer-related prostate-specific antigen. Clinical Chemistry, 48, 2187-2194.
9. Jeong, H. H., Erdene, N., Park, J. H., Jeong, D. H., Lee, H. Y., & Lee, S. K. (2013). Real-time label-free immunoas say of interferon-gamma and prostate-specific antigen using a fiber-optic localized surface plasmon resonance sensor. Biosensors and Bioelectronics, 39, 346-351. DOI: 10.1016/j.bios.2012.08.013.
10. Karlsson, R., Katsamba, P. S., Nordin, H., Pol, E., & Myszka, D. G. (2006). Analyzing a kinetic titration series using affinity biosensors. Analytical Biochemistry, 349, 136-147. DOI: 10.1016/j.ab.2005.09.034.
11. Katrlik , J., Skrabana, R., Misloviova, D., & Gemeiner, P. (2011). Binding of D-mannose-containing glycoproteins to D-mannose-specific lectins studied by surface plasmon resonance. Colloids and Surfaces A: Physicochemical and En gineering Aspects, 382, 198-202. DOI: 10.1016/j.colsurfa.2011. 01.020.
12. Katsamba, P. S., Navratilova, I., Calderon-Cacia, M., Fan, L., Thornton, K., Zhu, M., Bos, T. V., Forte, C., Friend, D., Laird-Offringa, I., Tavares, G., Whatley, J., Shi, E., Widom, A., Lindquist, K. C., Klakamp, S., Drake, A., Bohmann, D., Roell, M., Rose, L., Dorocke, J., Roth, B., Luginbühl, B., & Myszka, D. G. (2006). Kinetic analysis of a highaffinity antibody/antigen interaction performed by multiple Biacore users. Analytical Biochemistry, 352, 208-221. DOI: 10.1016/j.ab.2006.01.034.
13. Kuzmanov, U., Kosanam, H., & Diamandis, E. P. (2013). The sweet and sour of serological glycoprotein tumor biomarker quantification. BMC Medicine, 11, 31. DOI: 10.1186/1741-7015-11-31.
14. Madu, C. O., & Lu, Y. (2010). Novel diagnostic biomarkers for prostate cancer. Journal of Cancer, 1, 150-177. DOI: 10.7150/jca.1.150.
15. Mani, V., Wasalathanthri, D. P., Joshi, A. A., Kumar, C. V., & Rusling, J. F. (2012). Highly efficient binding of paramagnetic beads bioconjugated with 100 000 or more antibodies to protein-coated surfaces. Analytical Chemistry, 84, 10485-10491. DOI: 10.1021/ac3028257.
16. Nagasaki, H ., Watanabe, M., Komatsu, N., Kaneko, T. Y., Dube, J., Kajita, T., Saitoh, Y., & Ohta, Y. (1999). Epitope analysis of a prostate-specific antigen (PSA) C-terminalspecific monoclonal antibody and new aspects for the discrepancy between equimolar and skewed PSA assays. Clinical Chemistry, 45, 486-496.
17. Prensner, J. R., Rubin,M. A., Wei, J. T., & Chinnaiyan, A.M. (2012). Beyond PSA: The next generation of prostate cancer biomarkers. Science Translational Medicine, 4, 127rv3. DOI: 10.1126/scitranslmed.3003180.
18. Safina, G., Duran, I. B., Alasel, M., & Danielsson, B. (2011). Surface plasmon resonance for real-time stu dy of lectin-carbohydrate interactions for the differentiation and identification of glycoproteins. Talanta, 84, 1284-1290. DOI: 10.1016/j.talanta.2011.01.030.
19. Stephan, C., Ralla, B., & Jung, K. (2014). Pro state-specific antigen and other serum and urine markers in prostate cancer. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1846, 99-112. DOI: 10.1016/j.bbcan.2014.04.001.
20. Uludag Y.,Tothill I. E. 2012). Cancer biomarker detection in serum samples using surface plasmon resonance and quartz crystal microbalance sensors with nanoparticle signal amplification. Analytical Chemistry 84 5898-5904 10.1021/ac300278p.
21. Velonas, V. M., Woo, H. H., dos Remedios, C. G., & Assinder, S. J. (2013). Current status of biomarkers for prostate cancer. International Journal of Molecular Sciences, 14, 11034-11060. DOI: 10.3390/ijms140611034.